201 related articles for article (PubMed ID: 8278004)
1. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
Loeliger EA
Ned Tijdschr Geneeskd; 1993 Dec; 137(51):2669. PubMed ID: 8278004
[No Abstract] [Full Text] [Related]
2. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
Visser J
Ned Tijdschr Geneeskd; 1994 Feb; 138(8):426-7. PubMed ID: 8127387
[No Abstract] [Full Text] [Related]
3. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Loeliger EA
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2222-3. PubMed ID: 8247170
[No Abstract] [Full Text] [Related]
4. [No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
Urquhart J; Thijssen H; Struijker Boudier HA
Ned Tijdschr Geneeskd; 1994 Jan; 138(1):46-7. PubMed ID: 8289961
[No Abstract] [Full Text] [Related]
5. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
van der Meer FJ; Rosendaal FR
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2223-4; author reply 2224-5. PubMed ID: 8247172
[No Abstract] [Full Text] [Related]
6. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Verheugt FW
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2223. PubMed ID: 8247171
[No Abstract] [Full Text] [Related]
7. [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Houben JJ; Nicolai G
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2225; author reply 2225-6. PubMed ID: 8247173
[No Abstract] [Full Text] [Related]
8. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
Pfisterer M; Jockers G; Burkart F; Schmitt HE; Wolff G; Skarvan K; Stulz P; Hasse J; Grädel E
Schweiz Med Wochenschr; 1987 Oct; 117(43):1688-92. PubMed ID: 3501162
[TBL] [Abstract][Full Text] [Related]
9. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
Loeliger EA
Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
[No Abstract] [Full Text] [Related]
10. [The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
Harjola PT; Meurala H
Med Welt; 1981 Jul; 32(30-31):1178. PubMed ID: 7024707
[No Abstract] [Full Text] [Related]
11. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
Pfisterer M; Jockers G; Meier B; Schmitt HE; Stulz P; Hasse J; Grädel E; Burkart F
Helv Chir Acta; 1987 Feb; 53(4):497-500. PubMed ID: 3494713
[No Abstract] [Full Text] [Related]
12. [Double-blind study for the prevention of postoperative thrombosis].
Encke A; Stock C; Dumke HO
Chirurg; 1976 Dec; 47(12):670-3. PubMed ID: 1001131
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole and aspirin and patency of coronary bypass grafts.
von Schacky C
N Engl J Med; 1984 Jun; 310(23):1533-4. PubMed ID: 6609308
[No Abstract] [Full Text] [Related]
15. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Chesebro JH; Fuster V
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):90-3. PubMed ID: 7033674
[No Abstract] [Full Text] [Related]
16. Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
Chesebro JH; Fuster V
Int J Cardiol; 1983; 2(5-6):511-6. PubMed ID: 6341260
[No Abstract] [Full Text] [Related]
17. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Verstraete M
Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
[No Abstract] [Full Text] [Related]
18. [Thrombosis, embolism and aggregation inhibitors in surgery].
Zekert F
Fortschr Med; 1976 Nov; 94(31):1791-8. PubMed ID: 1002084
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective study of the use of dipyridamole and acetylsalicylic acid in the pre-, trans- and postoperative periods, in the prevention of thromboembolic complications, in high risk vascular surgery].
da Rocha Neto JM; da Rocha Filho JM; da Rocha AM
Arq Bras Cardiol; 1987 May; 48(5):327-32. PubMed ID: 3446130
[No Abstract] [Full Text] [Related]
20. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
Loeliger EA
Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
